Deleted Tweets From Scott Gottlieb, R-D.C.

RT @HHSGov: Statement from @SGottliebFDA and @DrAbernethyFDA. Read the full statement at: https://t.co/PArSVJcLFM https://t.co/MtW8V91xKz

RT @US_FDA: Commissioner @SGottliebFDA makes his final appearance before a House Appropriations Subcommittee as he discusses th… https://t.co/kVOpwTGbzU

Follow #FDA’s Principal Deputy Commissioner and Chief Information Officer Dr. Amy Abernathy on her brand new Twitter handle @DrAbernethyFDA - Welcome to FDA Twitter Amy!

RT @FDA_Drug_Info: Statement from FDA Commissioner @SGottliebFDA and Deputy Commissioner Anna Abram on new 2019 efforts to improve the quality of compounded drugs: https://t.co/4ijmkM5U0l.

RT @BioCentury: FDA outlines a regulatory framework specific to adaptive AI-based medical devices https://t.co/rEyvyVUmUY

Stem cell therapies hold out great promise, but there are too many products that are drugs and subject to regulation, that create significant potential risks to patients, but aren’t engaging FDA. We’ve laid out efficient pathways for proper development https://t.co/gX76zJ392I

#FDA is taking new steps to develop a modern regulatory framework to make sure that safe and effective artificial intelligence devices can efficiently advance to patients. We announced our new policy framework this week: https://t.co/aKEn2R0mes

Data suggest certain substances in the opioid kratom have potential for abuse. The findings of heavy metals in kratom strengthen our public health warnings around this substance and concern for the health and safety of Americans using it.

We’ve released #FDA lab tests results of 30 kratom products to determine if they contain heavy metals. The analysis found significant levels of lead and nickel at concentrations that exceed safe exposure for oral daily drug intake. https://t.co/QJIJ1q60Hn https://t.co/iopqeVe6Ib

RT @ddiamond: From AEI he came; to AEI he will return. Commissioner @SGottliebFDA is heading back to the conservative think tank after he leaves government this week, @lauriemcginley2 scoops. https://t.co/ELASXiKPUM https://t.co/M75ALxu9wj

RT @Health_Affairs: New on @Health_Affairs blog: "Rx Drug Policy At The @US_FDA: Looking Back At @SGottliebFDA And Ahead To Sharpless by @RESachs https://t.co/5GpMtiQxG1

RT @SGottliebFDA: THREAD: While we’re still learning about the long-term potential benefits and health risks of e-cigs, existing scie… https://t.co/N8UQtYoQYe

RT @angelicalavito: FDA is investigating nearly three dozen reports of seizures after vaping. Outgoing commissioner Scott Gottlieb is c… https://t.co/VpdWOOFzGi

#FDA today warned companies to stop making/selling e-liquids marketed to resemble Rx cough syrups as part of our continued work to crack down on misleading labeling/advertising and illegal/dangerous e-liquids that may entice youth or put consumers at risk: https://t.co/XttCCcwab1 https://t.co/OsRIiikexN

RT @califf001: People taking shortcuts for $$ jeopardizing pts. Good move by FDA to put them on notice. @dukeforge. FDA sends letters to 20 companies in attempt to rein in stem cell industry https://t.co/4XEVZleIc3

RT @FDA_Drug_Info: As we sunset the @SGottliebFDA handle, we wish a fond farewell to our trailblazing, tweetastic 23rd Commissioner. #FarewellDrG https://t.co/MZRg5ZmHbN

Today, we issued final guidance to clarify how the #FDA applies 6 factors that impact our decision-making process regarding whether a Risk Evaluation and Mitigation Strategy (REMS) is required for a drug. https://t.co/7mxKAFLSTY.

Today, for the first time since the first ARB impurity was discovered, we’re announcing that we’ve so far identified 40 ARB medications that we have concluded DO NOT contain nitrosamine impurities. https://t.co/nzjLayCJ2A https://t.co/bhAzUhrVc3

Efforts to encourage the innovation of novel and potentially less harmful products such as e-cigarettes for currently addicted adult smokers will be severely undermined if bad actors put the public, and kids in particular, at risk in this outrageous fashion. https://t.co/lhuze8rtEA

Follow #FDA’s Principal Deputy Commissioner and Chief Information Officer Amy Abernethy on her new Twitter handle @DrAbernethyFDA

RT @HHSGov: Statement from @SGottliebFDA and @DrAbernethyFDA. Read the full statement at: https://t.co/PArSVJcLFM https://t.co/MtW8V91xKz

RT @US_FDA: Commissioner @SGottliebFDA makes his final appearance before a House Appropriations Subcommittee as he discusses th… https://t.co/kVOpwTGbzU

Follow #FDA’s Principal Deputy Commissioner and Chief Information Officer Dr. Amy Abernathy on her brand new Twitter handle @DrAbernethyFDA - Welcome to FDA Twitter Amy!

RT @FDA_Drug_Info: Statement from FDA Commissioner @SGottliebFDA and Deputy Commissioner Anna Abram on new 2019 efforts to improve the quality of compounded drugs: https://t.co/4ijmkM5U0l.

RT @BioCentury: FDA outlines a regulatory framework specific to adaptive AI-based medical devices https://t.co/rEyvyVUmUY

Stem cell therapies hold out great promise, but there are too many products that are drugs and subject to regulation, that create significant potential risks to patients, but aren’t engaging FDA. We’ve laid out efficient pathways for proper development https://t.co/gX76zJ392I

#FDA is taking new steps to develop a modern regulatory framework to make sure that safe and effective artificial intelligence devices can efficiently advance to patients. We announced our new policy framework this week: https://t.co/aKEn2R0mes

Data suggest certain substances in the opioid kratom have potential for abuse. The findings of heavy metals in kratom strengthen our public health warnings around this substance and concern for the health and safety of Americans using it.

We’ve released #FDA lab tests results of 30 kratom products to determine if they contain heavy metals. The analysis found significant levels of lead and nickel at concentrations that exceed safe exposure for oral daily drug intake. https://t.co/QJIJ1q60Hn https://t.co/iopqeVe6Ib

RT @ddiamond: From AEI he came; to AEI he will return. Commissioner @SGottliebFDA is heading back to the conservative think tank after he leaves government this week, @lauriemcginley2 scoops. https://t.co/ELASXiKPUM https://t.co/M75ALxu9wj

RT @Health_Affairs: New on @Health_Affairs blog: "Rx Drug Policy At The @US_FDA: Looking Back At @SGottliebFDA And Ahead To Sharpless by @RESachs https://t.co/5GpMtiQxG1

RT @SGottliebFDA: THREAD: While we’re still learning about the long-term potential benefits and health risks of e-cigs, existing scie… https://t.co/N8UQtYoQYe

RT @angelicalavito: FDA is investigating nearly three dozen reports of seizures after vaping. Outgoing commissioner Scott Gottlieb is c… https://t.co/VpdWOOFzGi

#FDA today warned companies to stop making/selling e-liquids marketed to resemble Rx cough syrups as part of our continued work to crack down on misleading labeling/advertising and illegal/dangerous e-liquids that may entice youth or put consumers at risk: https://t.co/XttCCcwab1 https://t.co/OsRIiikexN

RT @califf001: People taking shortcuts for $$ jeopardizing pts. Good move by FDA to put them on notice. @dukeforge. FDA sends letters to 20 companies in attempt to rein in stem cell industry https://t.co/4XEVZleIc3

RT @FDA_Drug_Info: As we sunset the @SGottliebFDA handle, we wish a fond farewell to our trailblazing, tweetastic 23rd Commissioner. #FarewellDrG https://t.co/MZRg5ZmHbN

Today, we issued final guidance to clarify how the #FDA applies 6 factors that impact our decision-making process regarding whether a Risk Evaluation and Mitigation Strategy (REMS) is required for a drug. https://t.co/7mxKAFLSTY.

Today, for the first time since the first ARB impurity was discovered, we’re announcing that we’ve so far identified 40 ARB medications that we have concluded DO NOT contain nitrosamine impurities. https://t.co/nzjLayCJ2A https://t.co/bhAzUhrVc3

Efforts to encourage the innovation of novel and potentially less harmful products such as e-cigarettes for currently addicted adult smokers will be severely undermined if bad actors put the public, and kids in particular, at risk in this outrageous fashion. https://t.co/lhuze8rtEA

Follow #FDA’s Principal Deputy Commissioner and Chief Information Officer Amy Abernethy on her new Twitter handle @DrAbernethyFDA